A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs

被引:8
|
作者
Sajwani, Hawraa Sameer [1 ,2 ,3 ,4 ,5 ]
Williams, Anna, V [1 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Addict, London, England
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[4] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[5] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates
关键词
Opioid use; Opioid overdose; Opioid overdose death prevention; Take-home naloxone; Intranasal naloxone; Low- and middle-income countries; OPIOID OVERDOSE PREVENTION; OPIATE-OVERDOSE; HEROIN USERS; INJECT DRUGS; COST-EFFECTIVENESS; KNOWLEDGE; PEOPLE; ACCESS; INTERVENTION; CHALLENGES;
D O I
10.1186/s12954-022-00700-x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Opioid overdose epidemic is hitting record highs worldwide, accounting for 76% of mortality related to substance use. Take-home naloxone (THN) strategies are being implemented in many developed countries that suffer from high opioid overdose death rates. They aim to provide overdose identification and naloxone administration training, along with THN delivery to opioid users and others likely to witness an overdose incident such as family members and peers. However, little is known about such measures in low- and middle-income countries (LMIC), where opioid use and opioid-related deaths are reportedly high. This systematic literature review aims to examine the distribution of THN in LMIC, review studies identifying barriers to the implementation of THN programs worldwide, and assess their applicability to LMIC. Methods The literature was searched and analyzed for eligible studies with quality assessment. Results Two studies were found from LMIC on THN programs with promising results, and 13 studies were found on the barriers identified in implementing THN programs worldwide. The main barriers to THN strategies were the lack of training of healthcare providers, lack of privileges, time constraints, cost, legislative/policy restrictions, stigma, fear of litigation, and some misperceptions around THN. Conclusions The barriers outlined in this paper are probably applicable to LMIC, but more difficult to overcome considering the differences in their response to opioid overdose, their cultural attitudes and norms, the high cost, the waivers required, the legislative differences and the severe penalties for drug-related offenses in some of these countries. The solutions suggested to counter-act these obstacles can also be more difficult to achieve in LMIC. Further research is required in this area with larger sample sizes to provide a better understanding of the obstacles to the implementation, feasibility, accessibility, and utilization of THN programs in LMIC.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Take-home naloxone kits preventing overdose deaths
    Eggertson, Laura
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (01) : 17 - 17
  • [32] "Naloxone Can Save Lives!" - Take-Home Naloxone Programs as Prophylaxis of Opiate Overdose Fatalities
    Dichtl, A.
    Stoever, H.
    Dettmer, K.
    [J]. SUCHTTHERAPIE, 2016, 17 (03) : 137 - 143
  • [33] Rates of Naloxone Prescriptions Following Implementation of a Take-Home Naloxone Program from the Emergency Department
    Lebin, J. A.
    Chen, B. C.
    Korab, G.
    Jablonowski, K.
    Whiteside, L. K.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2017, 70 (04) : S101 - S101
  • [34] Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England
    Sondhi, Arun
    Ryan, George
    Day, Ed
    [J]. HARM REDUCTION JOURNAL, 2016, 13
  • [35] Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England
    Arun Sondhi
    George Ryan
    Ed Day
    [J]. Harm Reduction Journal, 13
  • [36] KNOWLEDGE OF NALOXONE AND TAKE-HOME NALOXONE PROGRAMS AMONG A SAMPLE OF PEOPLE WHO INJECT DRUGS IN AUSTRALIA
    Dietze, Paul M.
    Cogger, Shelley
    Malandkar, Dhanya
    Olsen, Anna
    Lenton, Simon
    [J]. DRUG AND ALCOHOL REVIEW, 2016, 35 : 11 - 11
  • [37] NEWS ANALYSIS Take-home message: improve naloxone supply
    Wise, Jacqui
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 359
  • [38] Take-home naloxone carriage among opioid users in Lanarkshire
    Hill, Duncan R.
    Al Azizi, Buthaina
    Conroy, Stephen
    Akram, Gazala
    [J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2021, 23 (03) : 45 - 50
  • [39] Effectiveness of Opioid Overdose and Take-Home Naloxone Training for Staff
    Mayet, S.
    Bhasme, P.
    Jaganthan, J.
    [J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 69 - 70
  • [40] Emergency department physicians' and pharmacists' perspectives on take-home naloxone
    Holland, Taylor J.
    Penm, Jonathan
    Dinh, Michael
    Aran, Sohileh
    Chaar, Betty
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 (02) : 169 - 176